Taplmmune Inc. began operations on January 1, 2013. Its post-closing trial balance at December 31, 2013 and 2014 is shown below along with some other information.

Other information regarding Taplmmune Inc. and its activities during 2014:
1. Assume all accounts have normal balances.
2. Cash dividends were declared and paid during the year.
3. Plant assets were sold for cash equal to book value during the year.

Required Using the information provided, prepare a statement of cash flows (applying the indirect method) for the year ended December 31, 2014.
Analysis Component: The net decrease in cash during 2014 for Taplmmune Inc. was $75 million. Briefly explain what caused this change using the statement of cash flows preparedabove.

Transcribed Image Text:

Taplmmune Inc. Post-Closing Trial Balance (millions of dollars) Taplmmune Inc. Income Statement For Year Ended December 31, 2014 (millions of dollars) December 31 2014 Cash 54 276 408 Property, plant and equipment.6,900 Accumulated depreciation..3,699 2013 129 372 261 8,976 4,125 309 405 Account Revenues: $26,700 Sales.... Cost of goods sold...$19,500 Depreciation expense.. Receivables Expenses 7,050 1,350 27,900 S 1,200 Total expenses. Accounts payable. Accrued liabilities 318 141 Bonds payable.1,200 600 2,100 2,700